Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi
Yıl: 2017 Cilt: 32 Sayı: Suppl. 1 Sayfa Aralığı: 11 - 22 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi
Öz: -
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Brie I. ESTRO Basic Clinical Radiobiology Course. Radioter Oncol Med 2007;1:88–91
- 2. Dale RG, Jones B. The clinical radiobiology of brachytherapy. Br J Radiol 1998;71(845):465–83.
- 3. Supe SS, Ganesh KM, Vaithianathan H, Sankar BN. Radiobiological quality of high dose rate interstitial brachytherapy treatments of carcinoma of the cervix. Reports of Practical Oncology and Radiotherapy 2006;11(1):13–22.
- 4. Zaider M, Hanin L. Tumor control probability in radiation treatment. Med Phys 2011;38(2):574–83.
- 5. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989;16(6):1623–30.
- 6. Rogers CL, Theodore N, Dickman CA, Sonntag VK, Thomas T, Lam S, et al. Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression. Int J Radiat Oncol Biol Phys 2002;54(2):505–13.
- 7. Armstrong JG, Fass DE, Bains M, Mychalczak B, Nori D, Arbit E, et al. Paraspinal tumors: techniques and results of brachytherapy. Int J Radiat Oncol Biol Phys 1991;20(4):787–90.
- 8. Stewart AJ, Hepel JT, O’Farrell DA, Devlin PM, Price LL, Dale RG, et al. Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Radiother Oncol 2013;108(2):232–5.
- 9. Saw CB, Suntharalingam N. Quantitative assessment of interstitial implants. Int J Radiat Oncol Biol Phys 1991;20(1):135–9.
- 10.Georg D, Kirisits C, Hillbrand M, Dimopoulos J, Pötter R. Image-guided radiotherapy for cervix cancer: hightech external beam therapy versus high-tech brachytherapy. Int J Radiat Oncol Biol Phys 2008;71(4):1272– 8.
- 11.Wazer DE, Kaufman S, Cuttino L, DiPetrillo T, Arthur DW. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 2006;64(2):489–95.
- 12.Pötter R, Haie-Meder C, Van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy- 3D dose volume parameters and aspects of 3D imagebased anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78(1):67–77.
- 13.Lambin P, Gerbaulet A, Kramar A, Scalliet P, HaieMeder C, Malaise EP, et al. Phase III trial comparing two low dose rates in brachytherapy of cervix carcinoma: report at two years. Int J Radiat Oncol Biol Phys 1993;25(3):405–12.
- 14.Haie-Meder C, Kramar A, Lambin P, Lancar R, Scalliet P, Bouzy J, et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma. Int J Radiat Oncol Biol Phys 1994;29(5):953–60.
- 15.Pierquin B, Chassagne D, Baillet F, Paine CH. Clinical observations on the time factor in interstitial radiotherapy using iridium-192. Clin Radiol 1973;24(4):506–9.
- 16.Visser AG, van den Aardweg GJ, Levendag PC. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments. Int J Radiat Oncol Biol Phys 1996;34(2):497–505.
- 17.Islam MA, Akramuzzaman MM, Zakaria GA. Dosimetric comparison between the microSelectron HDR (192)Ir v2 source and the BEBIG (60)Co source for HDR brachytherapy using the EGSnrc Monte Carlo transport code. J Med Phys 2012;37(4):219–25.
- 18.Richter J, Baier K, Flentje M. Comparison of 60cobalt and 192iridium sources in high dose rate afterloading brachytherapy. Strahlenther Onkol 2008;184(4):187– 92.
- 19.Park DW, Kim YS, Park SH, Choi EK, Ahn SD, Lee SW, et al. A comparison of dose distributions of HDR intracavitary brachytherapy using different sources and treatment planning systems. Appl Radiat Isot 2009;67(7-8):1426–31.
- 20.Strohmaier S, Zwierzchowski G. Comparison of (60) Co and (192)Ir sources in HDR brachytherapy. J Contemp Brachytherapy 2011;3(4):199–208.
- 21.Orton CG. Fractionated high dose rate versus low dose rate cervix cancer regimens. Br J Radiol 1991;64(768):1165–6.
- 22.Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1994;28(2):335–41.
- 23.Shigematsu Y, Nishiyama K, Masaki N, Inoue T, Miyata Y, Ikeda H, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys 1983;9(3):351–6.
- 24.Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1991;20(1):181–90.
- 25.Brenner DJ, Hall EJ, Huang Y, Sachs RK. Potential reduced late effects for pulsed brachytherapy compared with conventional LDR. Int J Radiat Oncol Biol Phys 1995;31(1):201–2.
- 26.Fowler J, Mount M. Pulsed brachytherapy: the conditions for no significant loss of therapeutic ratio compared with traditional low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992;23(3):661–9.
- 27.Fowler JF, Van Limbergen EF. Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997;37(4):877–83.
- 28.Roed H, Engelholm SA, Svendsen LB, Rosendal F, Olsen KJ. Pulsed dose rate (PDR) brachytherapy of anal carcinoma. Radiother Oncol 1996;41(2):131–4.
- 29.Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991;21(6):1425–34.
- 30.Kirkpatrick JP, van der Kogel AJ, Schultheiss TE. Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S42–9.
- 31.Start Trialists’ Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008;371(9618):1098–107.
- 32.Shaffer R, Pickles T, Lee R, Moiseenko V. Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure. Int J Radiat Oncol Biol Phys 2011;79(4):1029–36.
- 33.Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62(740):679–94.
- 34.Fowler JF, Dale RG. When Is a “BED” not a “BED”?- When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304). Int J Radiat Oncol Biol Phys 2010;78(2):640–1.
- 35.Clark BG, Souhami L, Roman TN, Chappell R, Evans MD, Fowler JF. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997;38(5):989–93.
- 36.Van Limbergen E, Joiner M, Van der Kogel A, Dörr W. Part I: The Basics of Brachytherapy. The GEC ESTRO Handbook of Brachytherapy. 2nd ed. Version 1;2015.
- 37.Bentzen SM, Dörr W, Gahbauer R, Howell RW, Joiner MC, Jones B, et al. Bioeffect modeling and equieffective dose concepts in radiation oncology- -terminology, quantities and units. Radiother Oncol 2012;105(2):266–8.
- 38.Thames HD. An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations. Int J Radiat Biol Relat Stud Phys Chem Med 1985;47(3):319–39.
- 39.Wouters BG, Begg AC. Irradiation-induced damage and the DNA damage response. In: Joiner M, van der Kogel A., editors. Basic Clinical Radiobiology. 4th ed. London: Hodder Arnold;2009: p. 11–26.
- 40.Orton CG. High-dose-rate brachytherapy may be radiobiologically superior to low-dose rate due to slow repair of late-responding normal tissue cells. Int J Radiat Oncol Biol Phys 2001;49(1):183–9.
- 41.Fowler JF. Is repair of DNA strand break damage from ionizing radiation second-order rather than first-order? A simpler explanation of apparently multiexponential repair. Radiat Res 1999;152(2):124–36.
- 42.Dörr W. Modulation of repopulation processes in oral mucosa: experimental results. Int J Radiat Biol 2003;79(7):531–7.
- 43.Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 1991;22(3):161–6.
- 44.Okkan S, Atkovar G, Sahinler I, Oner Dinçbaş F, Koca A, Köksal S, et al. Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience. Radiother Oncol 2003;67(1):97–105.
- 45.Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy. Radiother Oncol 2003;67(1):69–76.
- 46.Perez CA, Grigsby PW, Castro-Vita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1995;32(5):1275–88.
- 47.Petereit DG, Sarkaria JN, Potter DM, Schink JC. Highdose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence-the University of Wisconsin experience. Int J Radiat Oncol Biol Phys 1999;45(5):1267–74.
- 48.Wright EA, Howard-Flanders P. The influence of oxygen on the radiosensitivity of mammalian tissues. Acta radiol 1957;48(1):26–32.
- 49.Moulder JE, Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 1984;10(5):695–712.
- 50.Kallman RF. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology 1972;105(1):135–42.
- 51.Lee SW, Suh CO, Chung EJ, Kim GE. Dose optimization of fractionated external radiation and high-doserate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 2002;52(5):1338–44.
- 52.Bedford JS, Hall EJ. Threshold hypoxia: its effect on the survival of mammalian cells irradiated at high and low dose-rates. Br J Radiol 1966;39(468):896–900.
- 53.Girinski T, Pejovic-Lenfant MH, Bourhis J, Campana F, Cosset JM, Petit C, et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989;16(1):37–42.
- 54.Elkind MM, Sutton H. Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiat Res 1960;13:556–93.
- 55.Lara PC, López-Peñalver JJ, Farias Vde A, Ruiz-Ruiz MC, Oliver FJ, Ruiz de Almodóvar JM. Direct and bystander radiation effects: a biophysical model and clinical perspectives. Cancer Lett 2015;356(1):5–16.
- 56.Gómez-Millán J, Katz IS, Farias Vde A, Linares-Fernández JL, López-Peñalver J, Ortiz-Ferrón G, et al. The importance of bystander effects in radiation therapy in melanoma skin-cancer cells and umbilical-cord stromal stem cells. Radiother Oncol 2012;102(3):450–8.
- 57.Camphausen K, Moses MA, Ménard C, Sproull M, Beecken WD, Folkman J, et al. Radiation abscopal antitumor effect is mediated through p53. Cancer Res 2003;63(8):1990–3.
- 58.Takaya M, Niibe Y, Tsunoda S, Jobo T, Imai M, Kotani S, et al. Abscopal effect of radiation on toruliform para-aortic lymph node metastases of advanced uter- ine cervical carcinoma-a case report. Anticancer Res 2007;27(1B):499–503.
- 59.Demaria S, Bhardwaj N, McBride WH, Formenti SC. Combining radiotherapy and immunotherapy: a revived partnership. Int J Radiat Oncol Biol Phys 2005;63(3):655–66.
| APA | SAYNAK M, ÇUKURÇAYIR F, ARLI A, OKUMUŞ D (2017). Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. , 11 - 22. |
| Chicago | SAYNAK Mert,ÇUKURÇAYIR Funda,ARLI Ayşenur,OKUMUŞ Dilruba Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. (2017): 11 - 22. |
| MLA | SAYNAK Mert,ÇUKURÇAYIR Funda,ARLI Ayşenur,OKUMUŞ Dilruba Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. , 2017, ss.11 - 22. |
| AMA | SAYNAK M,ÇUKURÇAYIR F,ARLI A,OKUMUŞ D Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. . 2017; 11 - 22. |
| Vancouver | SAYNAK M,ÇUKURÇAYIR F,ARLI A,OKUMUŞ D Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. . 2017; 11 - 22. |
| IEEE | SAYNAK M,ÇUKURÇAYIR F,ARLI A,OKUMUŞ D "Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi." , ss.11 - 22, 2017. |
| ISNAD | SAYNAK, Mert vd. "Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi". (2017), 11-22. |
| APA | SAYNAK M, ÇUKURÇAYIR F, ARLI A, OKUMUŞ D (2017). Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. Türk Onkoloji Dergisi, 32(Suppl. 1), 11 - 22. |
| Chicago | SAYNAK Mert,ÇUKURÇAYIR Funda,ARLI Ayşenur,OKUMUŞ Dilruba Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. Türk Onkoloji Dergisi 32, no.Suppl. 1 (2017): 11 - 22. |
| MLA | SAYNAK Mert,ÇUKURÇAYIR Funda,ARLI Ayşenur,OKUMUŞ Dilruba Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. Türk Onkoloji Dergisi, vol.32, no.Suppl. 1, 2017, ss.11 - 22. |
| AMA | SAYNAK M,ÇUKURÇAYIR F,ARLI A,OKUMUŞ D Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. Türk Onkoloji Dergisi. 2017; 32(Suppl. 1): 11 - 22. |
| Vancouver | SAYNAK M,ÇUKURÇAYIR F,ARLI A,OKUMUŞ D Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi. Türk Onkoloji Dergisi. 2017; 32(Suppl. 1): 11 - 22. |
| IEEE | SAYNAK M,ÇUKURÇAYIR F,ARLI A,OKUMUŞ D "Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi." Türk Onkoloji Dergisi, 32, ss.11 - 22, 2017. |
| ISNAD | SAYNAK, Mert vd. "Yüksek Doz Hızlı Brakiterapi Radyobiyolojisi". Türk Onkoloji Dergisi 32/Suppl. 1 (2017), 11-22. |
